• Je něco špatně v tomto záznamu ?

Metastasising ameloblastoma or ameloblastic carcinoma? A case report with mutation analyses

P. Hurník, BM. Putnová, T. Ševčíková, E. Hrubá, I. Putnová, J. Škarda, M. Havel, O. Res, J. Cvek, M. Buchtová, J. Štembírek

. 2023 ; 23 (1) : 563. [pub] 20230812

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu přehledy, kazuistiky, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23016574

BACKGROUND: Ameloblastic carcinoma and metastasising ameloblastoma are rare epithelial odontogenic tumours with aggressive features. Distinguishing between these two lesions is often clinically difficult but necessary to predict tumour behaviour or to plan future therapy. Here, we provide a brief review of the literature available on these two types of lesions and present a new case report of a young man with an ameloblastoma displaying metastatic features. We also use this case to illustrate the similarities and differences between these two types of tumours and the difficulties of their differential diagnosis. CASE PRESENTATION: Our histopathological analyses uncovered a metastasising tumour with features of ameloblastic carcinoma, which developed from the ameloblastoma. We profiled the gene expression of Wnt pathway members in ameloblastoma sample of this patient, because multiple molecules of this pathway are involved in the establishing of cell polarity, cell migration or for epithelial-mesenchymal transition during tumour metastasis to evaluate features of tumor behaviour. Indeed, we found upregulation of several cell migration-related genes in our patient. Moreover, we uncovered somatic mutation BRAF p.V600E with known pathological role in cancerogenesis and germline heterozygous FANCA p.S858R mutation, whose interpretation in this context has not been discussed yet. CONCLUSIONS: In conclusion, we have uncovered a unique case of ameloblastic carcinoma associated with an alteration of Wnt signalling and the presence of BRAF mutation. Development of harmful state of our patient might be also supported by the germline mutation in one FANCA allele, however this has to be confirmed by further analyses.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016574
003      
CZ-PrNML
005      
20231026105720.0
007      
ta
008      
231013s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12903-023-03259-6 $2 doi
035    __
$a (PubMed)37573343
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Hurník, Pavel $u Laboratory of Molecular Morphogenesis, Institute of Animal Physiology and Genetics, Czech Academy of Sciences, Brno, Czech Republic $u Institute of Clinical and Molecular Pathology and Medical Genetics, Faculty Hospital and Medical Faculty Ostrava, Ostrava, Czech Republic $u Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
245    10
$a Metastasising ameloblastoma or ameloblastic carcinoma? A case report with mutation analyses / $c P. Hurník, BM. Putnová, T. Ševčíková, E. Hrubá, I. Putnová, J. Škarda, M. Havel, O. Res, J. Cvek, M. Buchtová, J. Štembírek
520    9_
$a BACKGROUND: Ameloblastic carcinoma and metastasising ameloblastoma are rare epithelial odontogenic tumours with aggressive features. Distinguishing between these two lesions is often clinically difficult but necessary to predict tumour behaviour or to plan future therapy. Here, we provide a brief review of the literature available on these two types of lesions and present a new case report of a young man with an ameloblastoma displaying metastatic features. We also use this case to illustrate the similarities and differences between these two types of tumours and the difficulties of their differential diagnosis. CASE PRESENTATION: Our histopathological analyses uncovered a metastasising tumour with features of ameloblastic carcinoma, which developed from the ameloblastoma. We profiled the gene expression of Wnt pathway members in ameloblastoma sample of this patient, because multiple molecules of this pathway are involved in the establishing of cell polarity, cell migration or for epithelial-mesenchymal transition during tumour metastasis to evaluate features of tumor behaviour. Indeed, we found upregulation of several cell migration-related genes in our patient. Moreover, we uncovered somatic mutation BRAF p.V600E with known pathological role in cancerogenesis and germline heterozygous FANCA p.S858R mutation, whose interpretation in this context has not been discussed yet. CONCLUSIONS: In conclusion, we have uncovered a unique case of ameloblastic carcinoma associated with an alteration of Wnt signalling and the presence of BRAF mutation. Development of harmful state of our patient might be also supported by the germline mutation in one FANCA allele, however this has to be confirmed by further analyses.
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé $7 D006801
650    12
$a ameloblastom $x genetika $x diagnóza $7 D000564
650    _2
$a protoonkogenní proteiny B-raf $x genetika $7 D048493
650    12
$a odontogenní nádory $x diagnóza $x genetika $7 D009808
650    _2
$a mutace $7 D009154
650    12
$a karcinom $x patologie $7 D002277
655    _2
$a přehledy $7 D016454
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Putnová, Barbora Moldovan $u Laboratory of Molecular Morphogenesis, Institute of Animal Physiology and Genetics, Czech Academy of Sciences, Brno, Czech Republic $u Department of Pathological Morphology and Parasitology, University of Veterinary Sciences, Brno, Czech Republic
700    1_
$a Ševčíková, Tereza $u Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Hrubá, Eva $u Laboratory of Molecular Morphogenesis, Institute of Animal Physiology and Genetics, Czech Academy of Sciences, Brno, Czech Republic
700    1_
$a Putnová, Iveta $u Laboratory of Molecular Morphogenesis, Institute of Animal Physiology and Genetics, Czech Academy of Sciences, Brno, Czech Republic $u Department of Anatomy, Histology and Embryology, University of Veterinary Sciences, Brno, Czech Republic
700    1_
$a Škarda, Josef $u Institute of Clinical and Molecular Pathology and Medical Genetics, Faculty Hospital and Medical Faculty Ostrava, Ostrava, Czech Republic $u Department of Clinical and Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University and University Hospital in Olomouc, Olomouc, Czech Republic
700    1_
$a Havel, Martin $u Department of Nuclear Medicine, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Res, Oldřich $u Department of Oral and Maxillofacial Surgery, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Cvek, Jakub $u Department of Oncology, Faculty of Medicine and University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Buchtová, Marcela $u Laboratory of Molecular Morphogenesis, Institute of Animal Physiology and Genetics, Czech Academy of Sciences, Brno, Czech Republic. buchtova@iach.cz $1 https://orcid.org/0000000202626774 $7 xx0043736
700    1_
$a Štembírek, Jan $u Laboratory of Molecular Morphogenesis, Institute of Animal Physiology and Genetics, Czech Academy of Sciences, Brno, Czech Republic. stembirek@iach.cz $u Department of Oral and Maxillofacial Surgery, University Hospital Ostrava, Ostrava, Czech Republic. stembirek@iach.cz
773    0_
$w MED00006812 $t BMC oral health $x 1472-6831 $g Roč. 23, č. 1 (2023), s. 563
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37573343 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026105715 $b ABA008
999    __
$a ok $b bmc $g 2000220 $s 1202936
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 23 $c 1 $d 563 $e 20230812 $i 1472-6831 $m BMC oral health $n BMC Oral Health $x MED00006812
LZP    __
$a Pubmed-20231013

Najít záznam

Citační ukazatele

Možnosti archivace